Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial
Abstract
Triple therapy with FF/UMEC/VI improved lung function in patients with moderate or severe uncontrolled asthma on ICS/LABA but did not lead to a reduction in moderate and/or severe exacerbations
Keywords
Efficacy and safety; Triple therapy; Inadequately controlled asthma
Bibliographic citation
Ojanguren I, Pilia MF. Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial. Breathe. 2021 Mar;17(1):200279.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/7129This item appears in following collections
- HVH - Articles científics [2476]
- VHIR - Articles científics [1012]
The following license files are associated with this item: